Session 154: RBMO LIVE 12: RGE AWARDS
Donate
At the International IVF Initiative, we are committed to providing free access to our educational sessions, webinars, and resources for professionals and individuals passionate about advancing reproductive medicine. We believe that cost should never be a barrier to knowledge and collaboration. By contributing, you’re ensuring that valuable educational resources, expert insights, and collaborative opportunities remain open to all without financial barriers. Together, we can continue to foster a global community dedicated to innovation and excellence in the field of IVF.
Your Donation
Thank you!
Session 154: RBMO LIVE 12: RGE AWARDS
Tuesday June 10, 3pm EST / 8pm BST/ 9pm CET
Moderators:
Dr. Mina Alikani and Prof. Juan García-Velasco
Presenters:
Prof. Sandro Esteves - APHRODITE criteria: Addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function
Dale Goss - Evaluation of an artificial intelligence-facilitated sperm detection tool in azoospermic samples for use in ICSI
Q and A
Synopsis
RBMO LIVE 12: The RGE Prize Session took place on Tuesday, June 10, bringing together global audiences for a dynamic discussion on groundbreaking research in male-factor infertility. Hosted by Reproductive BioMedicine Online, the webinar celebrated the winners of the 2025 Robert G. Edwards (RGE) Prize Paper Award, Prof. Sandro Esteves and Dale Goss. Moderators Dr. Mina Alikani and Prof. Juan García-Velasco, both esteemed editors of the journal, guided the session.
Prof. Esteves presented his work on the APHRODITE criteria, a proposed clinical framework designed to guide the evaluation and management of men with hypogonadism and/or unexplained testicular dysfunction. His research emphasizes a more structured and individualized approach to male infertility, aiming to fill current gaps in diagnosis and treatment strategies.
Dale Goss followed with a presentation on an innovative artificial intelligence-based sperm detection tool, developed for use in azoospermic samples during ICSI procedures. His study demonstrates how AI can assist embryologists in identifying rare sperm cells more efficiently and accurately, potentially increasing the chances of successful treatment in severe male infertility cases.
The session concluded with a lively Q&A, allowing attendees to ask questions and explore the clinical applications and implications of these findings. The webinar attracted clinicians, embryologists, researchers, and healthcare professionals from around the world, reflecting the global interest in advancing andrological care. Free and open to all, this event underscored RBMO’s commitment to highlighting impactful research and fostering international dialogue in reproductive medicine.
